EP0618804A4 - Peptide correspondant a des determinants antigeniques du virus du syndrome immunodeficitaire acquis htlv. - Google Patents

Peptide correspondant a des determinants antigeniques du virus du syndrome immunodeficitaire acquis htlv.

Info

Publication number
EP0618804A4
EP0618804A4 EP92922125A EP92922125A EP0618804A4 EP 0618804 A4 EP0618804 A4 EP 0618804A4 EP 92922125 A EP92922125 A EP 92922125A EP 92922125 A EP92922125 A EP 92922125A EP 0618804 A4 EP0618804 A4 EP 0618804A4
Authority
EP
European Patent Office
Prior art keywords
htlv
antigenic determinants
peptides corresponding
peptides
determinants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP92922125A
Other languages
German (de)
English (en)
Other versions
EP0618804A1 (fr
Inventor
Thomas J Palker
Barton F Haynes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Publication of EP0618804A1 publication Critical patent/EP0618804A1/fr
Publication of EP0618804A4 publication Critical patent/EP0618804A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP92922125A 1991-10-08 1992-10-08 Peptide correspondant a des determinants antigeniques du virus du syndrome immunodeficitaire acquis htlv. Withdrawn EP0618804A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77155391A 1991-10-08 1991-10-08
PCT/US1992/008405 WO1993006843A1 (fr) 1991-10-08 1992-10-08 Peptide correspondant a des determinants antigeniques du virus du syndrome immunodeficitaire acquis htlv
US771553 2001-01-30

Publications (2)

Publication Number Publication Date
EP0618804A1 EP0618804A1 (fr) 1994-10-12
EP0618804A4 true EP0618804A4 (fr) 1995-06-07

Family

ID=25092199

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92922125A Withdrawn EP0618804A4 (fr) 1991-10-08 1992-10-08 Peptide correspondant a des determinants antigeniques du virus du syndrome immunodeficitaire acquis htlv.

Country Status (4)

Country Link
EP (1) EP0618804A4 (fr)
JP (1) JPH07502493A (fr)
AU (1) AU2879292A (fr)
WO (1) WO1993006843A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2117378C (fr) * 1992-02-24 2003-04-15 Steven K. H. Foung Dosage et methode de detection de htlv-i/htlv-ii
MEP57508A (en) * 2002-12-20 2011-05-10 Amgen Inc Binding agents which inhibit myostatin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02209889A (ja) * 1988-02-08 1990-08-21 Univ Duke 合成親水性ペプチド

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525300A (en) * 1983-01-07 1985-06-25 Japanese Foundation For Cancer Research Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies
US4724258A (en) * 1984-02-03 1988-02-09 Juridical Foundation, Japanese Foundation For Cancer Research Adult T cell leukemia virus antigen polypeptide
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
US4833071A (en) * 1987-01-09 1989-05-23 United Biomedical, Inc. Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02209889A (ja) * 1988-02-08 1990-08-21 Univ Duke 合成親水性ペプチド

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
A KURATA ET AL.: "Immunodominant sites of human T cell lymphotropic virus type I envelope protein for murine helper T cells", JOURNAL OF IMMUNOLOGY., vol. 143, no. 6, 15 September 1989 (1989-09-15), BALTIMORE US, pages 2024 - 2030, XP002042560 *
DATABASE WPI Derwent World Patents Index; AN 90-344000, "Synthetic hydrophilic peptide-comprises 25 unit amino acid that corresponds to at least one antigen determinant of envelope sugar protein(s) of HTLV-I and HTLV-II" *
See also references of WO9306843A1 *
T J PALKER ET AL.: "Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoprotein", J. VIROL., vol. 66, no. 10, October 1992 (1992-10-01), BALTIMORE, US, pages 5879 - 5889, XP009033902 *
T J PALKER ET AL.: "Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelpoe glycoprotein with env-encoded synthetic peptides and a monoclonal antibody to gp 46", JOURNAL OF IMMUNOLOGY., vol. 142, no. 3, 1 February 1989 (1989-02-01), BALTIMORE US, pages 971-978 *

Also Published As

Publication number Publication date
WO1993006843A1 (fr) 1993-04-15
JPH07502493A (ja) 1995-03-16
EP0618804A1 (fr) 1994-10-12
AU2879292A (en) 1993-05-03

Similar Documents

Publication Publication Date Title
ZA928511B (en) Peptides
DE3787914D1 (de) Digitaler Videogenerator.
JPS5585553A (en) Novel peptide derivative
DE68923227D1 (de) Vektor-zu-Raster-Umwandlungsverfahren.
AU111508S (en) Armchair
AU111083S (en) Armchair
PH21382A (en) A-21978c cyclic peptide derivative
AU112867S (en) An armchair
EP0618804A4 (fr) Peptide correspondant a des determinants antigeniques du virus du syndrome immunodeficitaire acquis htlv.
GB8628401D0 (en) Stretch wrapping
ZA915978B (en) Peptides
EP0671931A4 (fr) Peptides hemoregulateurs.
GB2023414B (en) Collapsible armchair
GB8818340D0 (en) Antigenic determinants
GB8817557D0 (en) Antigenic determinants
AU7258491A (en) Htlv envelope antigenic segment
JPS54144367A (en) Novel peptide
CS646086A1 (en) Zariadenie pre cistenie odpadovych vod
ZA916490B (en) Footrot vaccine
IE813106L (en) Ldh-c4 antigenic peptide
CA65175S (en) Sofa group
GB9117602D0 (en) Novel antigens
GB9122301D0 (en) Novel antigens
GB2013485B (en) Chairs
GB9106617D0 (en) Upright actions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940418

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK FR GB IT LI SE

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK FR GB IT LI SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970501